Charlotte Bradbury: Adding Mycophenolate to Corticosteroid for ITP
Mycophenolate alongside corticosteroids may be considered as an effective first-line treatment option for some patients with immune thrombocytopenia. Charlotte Bradbury, MD, discusses results from...
José Blanco: Accessory Splenectomy in Patients with Immune Cytopenias
José Blanco, MD, discusses whether searching for an accessory spleen or performing accessory splenectomy is a safe and effective treatment for patients with refractory...
Anthony Mato: LOXO-305 Demonstrates Efficacy in Patients With CLL/SLL
Anthony Mato, MD, shares findings from a phase I/II trial evaluating LOXO-305 in patients with heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Tippi MacKenzie: In Utero Hematopoietic Cell Transplantation for Hematologic Conditions
In utero hematopoietic cell transplantation showed promise in a phase 1 clinical trial involving fetuses with alpha thalassemia major. Here, Tippi Mackenzie, MD, discusses...
Amy Shapiro: SIG-001 Cell Therapy for Hemophilia A
Amy Shapiro, MD, discusses results from a first-in-human phase I/II trial assessing SIG-001 in patients with hemophilia A.
Simon Harrison: Early Data on AMG 701 for Heavily Pretreated Relapsed/Refractory Multiple Myeloma
Simon Harrison, MBBS, PhD, shares results from a phase I first-in-human trial evaluating AMG 701, an anti‑BCMA BiTE® molecule, in patients with heavily pre‑treated...
Andreas Hochhaus: Asciminib vs. Bosutinib in Chronic Myeloid Leukemia
Andreas Hochhaus, MD, discusses results from a phase I study suggesting asciminib may have superior efficacy to bosutinib in patients with heavily pretreated chronic...
Nichola Cooper: Fostamatinib in Warm Antibody Autoimmune Hemolytic Anemia
Patients with warm antibody autoimmune hemolytic anemia (wAIHA) had markedly improved hemoglobin levels after fostamatinib treatment. Here, Nichola Cooper, MD, shares results from a phase...
Jacqueline Garcia: Evaluating Venetoclax Plus Azacitidine in Patients with High-Risk MDS
Jacqueline Garcia, MD, discusses results from a phase Ib study evaluating venetoclax and azacitidine in patients with treatment-naïve high-risk myelodysplastic syndromes.
Alfred Garfall: Evaluating Teclistamab in Relapsed and/or Refractory Multiple Myeloma
Alfred Garfall, MD, discusses updated safety and efficacy data from a phase I trial evaluating teclistamab, a bispecific BCMA x CD3 antibody, for the...
Current Issue
March 2021 Volume 7 Issue 4
This issue examines blood services across the globe, the repercussions of increased patient access to medical information, and more.